Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"